Dow Up 0.36% Nasdaq Up 0.12%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.11 Down 0.12(2.84%) Aug 21, 4:00PM EDT
|After Hours : 4.12 Up 0.01 (0.24%) Aug 21, 7:59PM EDT
Prev Close:4.23
Open:4.23
Bid:4.08 x 300
Ask:4.12 x 300
1y Target Est:7.06
Beta:-2.36
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.05 - 4.27
52wk Range:4.05 - 7.97
Volume:5,512,570
Avg Vol (3m):4,931,970
Market Cap:903.52M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 2.84%903.52M
GSKDown 0.23%114.58B
OREXDown 1.56%695.99M
RHHBYDown 0.02%247.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback